Literature DB >> 21623885

Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept.

J Kluk1, J M R Goulding, J Bhat, T M Finch.   

Abstract

Bullous pemphigoid (BP) is one of the most common acquired immunobullous diseases. Rarely, the development of BP is attributed to drug exposure. We present two cases of BP, one triggered by intravenous iodine, and one associated with etanercept treatment in a patient with psoriasis; the first time, to our knowledge, that either of these associations has been reported. The recognition of occasional cases of drug-induced BP such as ours, with timely cessation of the offending agent, may produce rapid clinical improvement with decreased exposure to potent immunosuppressive therapy. © The Author(s). CED
© 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623885     DOI: 10.1111/j.1365-2230.2011.04102.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Bullous pemphigoid occurring under anti-tumor necrosis factor-α therapy.

Authors:  M Ricci; Stefania Zauli; A Zelante; L Trevisani; A Virgili; V Bettoli
Journal:  Int J Colorectal Dis       Date:  2014-06-24       Impact factor: 2.571

Review 2.  Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2022-08-14       Impact factor: 6.233

3.  Bullous pemphigoid induced by ustekinumab: a case report.

Authors:  Marta Marin; Natalia Alzueta; Marta Castresana; Ana Gascón; María Pío
Journal:  Eur J Hosp Pharm       Date:  2019-05-30

Review 4.  Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.

Authors:  Martina Burlando; Niccolò Capurro; Astrid Herzum; Emanuele Cozzani; Aurora Parodi
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

5.  Etanercept-induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient.

Authors:  Erin N Wilmer; Nils Becker; Allison Chen; George Kroumpouzos
Journal:  JAAD Case Rep       Date:  2016-01-22

6.  Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture.

Authors:  Forum Patel; Reason Wilken; Falin B Patel; Hawa Sultani; Itzel Bustos; Christopher Duong; John J Zone; Siba P Raychaudhuri; Emanual Maverakis
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

Review 7.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

8.  Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.

Authors:  Noritada Yoshikawa; Erika Matsubara; Motohisa Yamamoto; Hiroki Yamazaki; Masaaki Uehara; Masahiro Kamata; Hirotoshi Tanaka
Journal:  Intern Med       Date:  2020-07-07       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.